|
Have you recently been hospitalized for ACS? If so, you may qualify for this study in which your residual cardiovascular risk may benefit from an increase in HDL-C.
If you qualify for this study, you will be provided at no cost to you:
- Study related medication.
- Study related medical care, including doctor visits, tests and lab work.
In addition, you may be eligible to receive financial compensation for your time and travel.
Participate in the Acute Coronary Syndrome study. |